Publication list
2024
Nagy, L.,
Mezősi-Csaplár, M.,
Rebenku, I.,
Vereb, G.,
Szöőr, Á.:
Universal CAR T cells targeted to HER2 with a biotin-trastuzumab soluble linker penetrate spheroids and large tumor xenografts that are inherently resistant to trastuzumab mediated ADCC.
Front. Immunol. 15 1-38, 2024.
Journal metrics:
Q1 Immunology (2023)
Q1 Immunology and Allergy (2023)
2022
Sipos, F.,
Bohusné Barta, B.,
Simon, Á.,
Nagy, L.,
Dankó, T.,
Raffay, R.,
Petővári, G.,
Zsiros, V.,
Wichmann, B.,
Sebestyén, A.,
Műzes, G.:
Survival of HT29 Cancer Cells Is Affected by IGF1R Inhibition via Modulation of Self-DNA-Triggered TLR9 Signaling and the Autophagy Response.
Pathol. Oncol. Res. 28 1-15, 2022.
Journal metrics:
Q3 Cancer Research
Q2 Medicine (miscellaneous)
Q3 Oncology
Q2 Pathology and Forensic Medicine
Bohusné Barta, B.,
Simon, Á.,
Nagy, L.,
Dankó, T.,
Raffay, R.,
Petővári, G.,
Zsiros, V.,
Sebestyén, A.,
Sipos, F.,
Műzes, G.:
Survival of HT29 cancer cells is influenced by hepatocyte growth factor receptor inhibition through modulation of self-DNA-triggered TLR9-dependent autophagy response.
PLoS One. 17 (5), 1-25, 2022.
2019
Műzes, G.,
Sebestyén, A.,
Simon, Á.,
Nagy, L.,
Barta, B.,
Danko, T.,
Kiss, A.,
Sipos, F.:
IGF1R inhibition affects the survival of HT29 cancer cells by alterations of the TLR9- and autophagy signaling.
Ann. Oncol. 30 (Suppl_5), 806-807, 2019.
Sipos, F.,
Nagy, L.,
Barta, B.,
Simon, Á.,
Danko, T.,
Sebestyén, A.,
Kiss, A.,
Műzes, G.:
Modulation of TLR9-dependent autophagy response via inhibition of c-Met signaling influences the survival of HT29 cancer cells.
Ann. Oncol. 30 (Suppl_5), v807, 2019.
updated: 2024-11-10, 01:20
